Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human osteoblast treated with recombinant TGF-beta

ABSTRACT: Global expression profile of human osteoblast treated with recombinant TGF-beta compared to human osteoblast treated with growth media alone

ORGANISM(S): Homo sapiens

PROVIDER: GSE17843 | GEO | 2010/09/30

SECONDARY ACCESSION(S): PRJNA123541

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Human osteoblast treated with recombinant TGF-beta

Project description:Global expression profile of human osteoblast treated with recombinant TGF-beta compared to human osteoblast treated with growth media alone Dye-swap design with 6 biological replicates. Three arrays performed with TGF-beta treated samples on channel 1 and media-alone treated on channel 2; three arrays performed with TGF-beta treated samples on channel 2 and media-alone on channel 1.

2010-09-29 | E-GEOD-17843 | biostudies-arrayexpress

Expression profiles of human osteoblasts directly and indirectly damaged by chemotherapy

Project description:This SuperSeries is composed of the following subset Series: GSE17839: Human osteoblast treated with Melphalen GSE17842: Human osteoblast treated with chemotherapy-treated bone marrow stromal cell conditioned media GSE17843: Human osteoblast treated with recombinant TGF-beta Refer to individual Series

2010-09-30 | E-GEOD-17860 | biostudies-arrayexpress

Homo sapiens

Project description:Human osteoblast treated with recombinant TGF-beta

| PRJNA123541 | ENA

Human osteoblast treated with chemotherapy-treated bone marrow stromal cell conditioned media

2010-09-30 | GSE17842 | GEO

Human osteoblast treated with chemotherapy-treated bone marrow stromal cell conditioned media

Project description:Global expression profile of human osteoblast treated with chemotherapy-treated bone marrow stromal cell conditioned media, compared to human osteoblast cells treated with diluent-control bone marrow stromal cell conditioned media. Goal is to identify genes regulated by chemotherapy in osteoblasts. Dye-swap design with 6 biological replicates. Three arrays performed with chemotherapy treated samples on channel 1 and diluent-control treated on channel 2; three arrays performed with chemotherapy treated samples on channel 2 and diluent-control on channel 1.

2010-09-30 | E-GEOD-17842 | biostudies-arrayexpress

Human osteoblast treated with Melphalen

Project description:Global expression profile of human osteoblast treated with melphalen, compared to human osteoblast cells treated with diluent control

2010-09-30 | GSE17839 | GEO

TGF-beta responsive gene in primary osteoblast.

Project description:Gene expression profiling of a total of 3,774 genes in primary osteoblastic cells treated with TGF-beta1 Keywords: cytokine response Primary osteoblasts cultured under serum-starved condition were treated or untreated with TGF-beta1 for 24 hr.

2009-04-28 | E-GEOD-11702 | biostudies-arrayexpress

Effect of recombinant protein CXCL12 on patient-derived glioblastoma stem cells

Project description:To investigate the effect of recombinant CXCL12 on patient-derived glioblastoma stem cells, we treated GSCs with recombinant CXCL12 in cell culture media

2023-12-01 | GSE219288 | GEO

TGF-beta responsive gene in primary osteoblast.

Project description:Gene expression profiling of a total of 3,774 genes in primary osteoblastic cells treated with TGF-beta1 Keywords: cytokine response

2009-04-28 | GSE11702 | GEO

Quantitative Proteomics analysis of LX-2 Responses to Irradiation and TGF-β1 Description

Project description:The human hepatic stellate cell line LX2 was treated with 8 Gy X-ray irradiation and/or 2ng/ml recombinant human TGF-β1. The iTRAQ-based high throughput quantitative proteomic approach was used to obtain a comprehensive view of the protein ensembles affected by irradiation and/or TGF-β1 treatment on LX2. This study provides clues for further investigation of the mechanisms behind radiation-induced liver fibrosis.

2018-12-04 | PXD011242 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data